Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06808113

Circulating and Molecular Markers Involved in the Processes of Cachexia, Anorexia and Sarcopenia in Patients With NSCLC

Study of Circulating and Molecular Markers Functionally Involved in the Processes of Cachexia, Anorexia and Sarcopenia in Patients With Advanced Non-small Cell Lung Cancer (NSCLC).

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study aim to evaluate whether some substances produced by muscle or adipose tissue may play a role in the course of the disease by interfering with the effectiveness of therapies.

Detailed description

The study is aimed at patients with NSCLC in whom plasma levels of particular biomarkers will be studied before and after treatment with chemotherapy and immunotherapy or immunotherapy alone. In particular, the plasma levels of GDF15, FGF21, HN, Activin molecules and microRNAs involved in inflammatory processes, called inflammamiR, in particular of microRNA146, 126, 21, 188, 155, will be studied. Assessments of cellular markers of leukocyte aging will also be performed (determination of telomere length is a widely used measure of biological aging)

Conditions

Timeline

Start date
2022-11-07
Primary completion
2024-10-07
Completion
2027-08-01
First posted
2025-02-05
Last updated
2025-02-05

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06808113. Inclusion in this directory is not an endorsement.